N-{5-bromoimidazo[1,2-a]pyridin-2-yl}cyclopropanecarboxamide, 97.0%, 10g

1-(2-Methoxy-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid, 95.0%, 1g

1-hydroxyl-1H-pyridine-2-thione, 1g

5-BROMO-4-METHYLNICOTINIC ACID, 95.0%, 250mg

Methyl 4-(4-iodophenoxy)benzoate, 95.0%, 250mg

2-Methoxy-5-methylphenylboronic acid, 97.0%, 25g

Single-channel microliter pipette Acura® manual Fixed volume, 100 µl, 815, 1 piece

Lawessons reagent, 98.0%, 4x25g

3,5-Dichlorobenzotrifluoride, 97.0%, 5g

3-(3-methyl-1,2,4-oxadiazol-5-yl)-4,7-dihydro-5H-thieno[2,3-c]pyran-2-amine, 95.0%, 250mg

(1-Methylcyclohexyl)methanol, 97%, 1g

4-Benzyloxy-3,3-dimethylbut-1-yne, 95.0%, 25g

5-acetyl-6-amino-1-benzylpyrimidine-2,4(1H,3H)-dione, 100mg